| Standard protocol |
| mAB generation |
description |
cat. no. |
| Phase I/Immunization |
3 Balb/c mice, 17 days immunization, pre-bleeding, immune serum |
2-2601-001 |
| Phase II/Fusion |
Preparation of lymphocytes, fusion with myeloma cell line, selection |
2-2601-002 |
| Phase III/Screening and subcloning, ELISA screening and production |
ELISA screening, subcloning by limiting dilution, second ELISA screening, production of 100 ml supernatant of selected antibody |
2-2601-003 |
| Optional Western blot screening |
Screening of max. 72 ELISA positive oligoclones in a Western blot against the antigen provided by the customer |
2-2601-004 |
| Optional immunofluorescence screening |
Screening of max. 360 oligoclones in an immunofluorescence assay against target cells provided by the customer |
2-2601-005 |